Cabinet has approved establishment of Ghana Medical Equipment Services Ltd – Mahama

Ghana has taken a significant step towards enhancing its healthcare infrastructure with the Cabinet's approval for the establishment of Ghana Medical Equipment Services Limited (GMESL). This new entity, a subsidiary of the Ghana Medical Trust Fund (GMTF), is designed to address persistent challenges in the management, maintenance, and efficient utilisation of medical equipment across major hospitals in the country. The move aims to ensure the longevity of substantial investments in healthcare technology and prevent the premature breakdown of critical medical devices, a problem that has historically plagued Ghana's health facilities. GMESL is expected to provide a dedicated, professionally managed framework for equipment lifecycle management, staffed by specialised biomedical engineers, thereby improving healthcare delivery and optimising public funds. Its establishment builds upon the broader legal framework governing healthcare in Ghana, including the Ghana Medical Trust Fund Act, 2025 (Act 1144), and the Public Health Act, 2012 (Act 851).

Ghana's healthcare sector is poised for a transformative shift with the recent Cabinet approval for the establishment of Ghana Medical Equipment Services Limited (GMESL). Announced by former President John Dramani Mahama, GMESL is envisioned as a crucial subsidiary of the Ghana Medical Trust Fund (GMTF), tasked with the comprehensive oversight of medical equipment management, maintenance, and efficient deployment within the nation's principal hospitals. This strategic initiative directly confronts the long-standing issue of inadequate maintenance leading to the premature failure of expensive medical apparatus, a challenge that has historically undermined significant government investments in healthcare infrastructure.

The creation of GMESL signals a deliberate pivot towards a more sustainable and professionally managed approach to healthcare technology. By centralising the management and maintenance functions under a dedicated entity, Ghana aims to safeguard its medical investments, ensure the continuous functionality of critical equipment, and ultimately enhance the quality and accessibility of healthcare services for its citizens. This article will delve into the legal underpinnings of GMESL's establishment, its operational mandate within Ghana's existing healthcare legal framework, and the potential implications for legal practitioners and the broader health sector.

The establishment of Ghana Medical Equipment Services Limited (GMESL) is rooted in a broader legislative and policy landscape aimed at strengthening Ghana's healthcare system. Central to this is the Ghana Medical Trust Fund (GMTF), which was formally established by the Ghana Medical Trust Fund Act, 2025 (Act 1144) in July 2025. The GMTF is a national statutory fund designed to mobilise sustainable financing for specialised medical care, particularly for chronic non-communicable diseases, and to invest in medical equipment and healthcare infrastructure.

The legal framework for healthcare in Ghana is multifaceted, encompassing several key statutes. The Ghana Health Service and Teaching Hospitals Act, 1996 (Act 525), established the Ghana Health Service (GHS) as the primary body for implementing national health policies and managing public sector health services. Additionally, the Public Health Act, 2012 (Act 851), governs public health issues, including disease prevention, environmental health, and the regulation of medical devices. The regulatory oversight for medical devices, including their registration and quality standards, falls under the purview of the Ghana Food and Drugs Authority (FDA). The Companies Act, 2019 (Act 992), provides the general legal framework for the incorporation and operation of companies in Ghana, which would be relevant if GMESL is structured as a limited liability company. Furthermore, the Public Private Partnership Act, 2020 (Act 1039), offers a framework for collaborations between public and private entities in the provision of infrastructure and services, which could be relevant to GMESL's operational model.

The announcement of GMESL as a subsidiary of the Ghana Medical Trust Fund (GMTF) presents an interesting legal and operational structure. While the GMTF itself is a statutory fund established by Act 1144, the precise legal nature of GMESL requires further examination. The statement that "Cabinet has approved establishment" suggests an executive directive. If GMESL is to operate as a public corporation, Article 192 of the 1992 Constitution of Ghana mandates its establishment by an Act of Parliament. However, as a *subsidiary* of a statutory fund, it is plausible that GMESL could be incorporated as a limited liability company under the Companies Act, 2019 (Act 992), with the GMTF as its sole or primary shareholder. This would grant it a degree of operational flexibility while still being accountable through its parent entity, the GMTF.

The core mandate of GMESL – the management, maintenance, and efficient use of medical equipment – directly addresses a critical gap identified in Ghana's healthcare system. Former President Mahama highlighted that a previous US$250 million investment in equipping hospitals with modern medical equipment suffered from a lack of proper maintenance, leading to premature breakdowns. GMESL's role is to rectify this by providing a dedicated structure staffed by specialised biomedical engineers. This aligns with the broader objectives of the Ghana Health Service (GHS) under Act 525, which includes prudently managing resources and ensuring access to improved health services.

The operationalisation of GMESL will likely interact with existing regulations governing medical devices in Ghana. The Food and Drugs Authority (FDA), under the Public Health Act, 2012 (Act 851), is responsible for the regulation and registration of medical devices, ensuring their safety and effectiveness. GMESL's activities, particularly in procurement, maintenance, and eventual replacement of equipment, will need to strictly adhere to these FDA guidelines, including requirements for quality management systems, post-market surveillance, and technical documentation. Furthermore, the project's scope, involving the supply of modern medical equipment and technical training to hospitals, suggests a potential for public-private partnerships, which are governed by the Public Private Partnership Act, 2020 (Act 1039).

One potential area of legal consideration could be the funding mechanisms for GMESL's operations. The Ghana Medical Trust Fund, its parent body, is financed through an uncapped National Health Insurance Levy, government budgetary allocations, and corporate contributions. However, the allocation of 20% of the National Health Insurance Scheme (NHIS) levy to the GMTF has been a point of contention, with concerns raised about its potential impact on the existing NHIS. This financial interdependence means that the sustainability and operational capacity of GMESL will be directly linked to the robust and equitable funding of the GMTF, and any challenges to the GMTF's funding model could indirectly affect GMESL's ability to fulfill its mandate.

The establishment of Ghana Medical Equipment Services Limited (GMESL) marks a pivotal development in Ghana's efforts to build a resilient and efficient healthcare system. By creating a dedicated entity for medical equipment management and maintenance, the government aims to overcome historical challenges of equipment breakdown and ensure optimal utilisation of healthcare investments. Legal practitioners should closely monitor the specific legislative instrument that formally establishes GMESL, particularly whether it is incorporated under the Companies Act, 2019 (Act 992), or if a new Act of Parliament is enacted, given its public service mandate. The governance structure, funding mechanisms, and accountability frameworks of GMESL, especially its relationship with the Ghana Medical Trust Fund and the broader Ministry of Health and Ghana Health Service, will be crucial areas for legal scrutiny.

Practitioners advising clients in the healthcare sector, particularly those involved in medical device supply, maintenance, or healthcare infrastructure development, should familiarise themselves with GMESL's operational guidelines once they are promulgated. Understanding the interplay between GMESL's mandate, the Public Health Act, 2012 (Act 851), FDA regulations for medical devices, and the Public Private Partnership Act, 2020 (Act 1039), will be essential. The success of GMESL will not only depend on its operational efficiency but also on a clear and robust legal framework that ensures its sustainability, transparency, and effective collaboration with both public and private sector stakeholders in Ghana's evolving healthcare landscape.